Efficacy and tolerability of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: sex and age effects and effect size across the day

BACKGROUND: Efficacy and safety profiles by sex and age (6-9 vs 10-12 years) and magnitude and duration of effect by effect size overall and across the day of lisdexamfetamine dimesylate (LDX) vs placebo were assessed. METHODS: This study enrolled children (6-12 years) with attention-deficit/hyperac...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Wigal, Sharon B, Kollins, Scott H, Childress, Ann C, Adeyi, Ben
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2010
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3022598/
https://ncbi.nlm.nih.gov/pubmed/21156071
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1753-2000-4-32
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller